Warfarin Drug-to-Drug Interaction (DDI) Project

TMF proposes a unique quality improvement project that targets warfarin with amiodarone as a preventable drug-drug interaction (DDI). The project would prevent and reduce both emergency department1 and inpatient hospitalizations that are due to adverse events attributable to the use of warfarin with other drugs in the elderly population in Texas.

Project Resources

Project resources for warfarin drug-to-drug interactions (DDI) are provided on these pages:

• Articles
• Tools
• Websites
• Guidelines

Warfarin Drug-to-Drug Interaction (DDI) Guidelines

Anticoagulation Guidelines

The guidelines are grouped according to the following categories:

• General or broad consensus reports
• Cardiac
• Stroke/TIA
• Venous Thromboembolism
• Peripheral artery disease
• Bleeding complications

Contact Information

Jim Turpin
Quality Improvement Consultant
DrugSafety@tmf.org 
1-866-439-5863, ext. 644
512-334-1787 fax

Source

1“Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults,” Annals of Internal Medicine, 4 December 2007, Volume 147, Issue 11, pages 755-765.